SCHEMBL4421804

SCHEMBL4421804

CCCCC(N)(CCN)CCCC

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.44
DNM1 Q05193 8/20 0.41
TSHR P16473 2/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ALDH1A1 P00352 1/20 0.41
EPHX1 P07099 1/20 0.41
SMPD1 P17405 2/20 0.37
LMNA P02545 1/20 0.32
TNNC1 P63316 2/20 0.31
SGPL1 O95470 1/20 0.31
S1PR4 O95977 1/20 0.31
S1PR1 P21453 1/20 0.31
GPR183 P32249 1/20 0.31
CERS2 Q96G23 1/20 0.31
S1PR3 Q99500 1/20 0.31
S1PR5 Q9H228 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5792250 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL11775656 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL9411168 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL11771930 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL10795207 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL27570389 0.90 DNM1 (0.50) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL11774607 0.89 DNM1 (0.48) FDPSDNM1TSHRMEN1KMT2A
SCHEMBL93609 0.88 FDPS (0.46) FDPSDNM1TSHRMEN1KMT2A
Fluoride SCHEMBL4871826 0.85 FDPS (0.44) FDPSDNM1TSHRMEN1KMT2A
Hydrochloric Acid SCHEMBL363004 0.85 FDPS (0.44) FDPSDNM1TSHRSMPD1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2648826-A1 PROCESS FOR REMOVING CARBON DIOXIDE FROM A GAS STREAM Shell Internationale Research Maatschappij B.V. (NL) 2013-10-16 EP claimed
WO-2013102795-A1 ANTIMICROBIAL POLYMER COMPOUNDS, PROCESS FOR THE PREPARATION AND USES THEREOF SAS SPIRIENCE (FR) 2013-07-11 WO claimed
WO-2012076597-A1 PROCESS FOR REMOVING CARBON DIOXIDE FROM A GAS STREAM SHELL INTERNATIONALE RESEARCH MAATSCHAPPIJ B.V. (NL) 2012-06-14 WO claimed
EP-2046484-A1 SEPARATING CO2 FROM GAS MIXTURES Universität Dortmund (DE) 2009-04-15 EP claimed
WO-2008015217-A1 SEPARATING CO2 FROM GAS MIXTURES Universität Dortmund (DE) 2008-02-07 WO claimed
EP-1373425-A2 PROTECTIVE ARTICLES 3M Innovative Properties Company (US) 2004-01-02 EP claimed
WO-2002070623-A2 PROTECTIVE ARTICLES 3M INNOVATIVE PROPERTIES COMPANY (US) 2002-09-12 WO claimed
CN-117157281-A Targeted delivery of 1,2,4, 5-tetraoxacompounds and uses thereof 西湖大学 2023-12-01 CN disclosed
WO-2023114188-A1 IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-06-22 WO disclosed
US-20230183168-A1 IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2023-06-15 US disclosed
CN-107474885-B Fuel composition 因诺斯佩克有限公司 2019-11-05 CN disclosed
CN-106795366-B Solidification compound and its solidfied material 株式会社钟化 2019-05-07 CN disclosed
CN-109081797-A Diesel oil detergent without low molecular weight loss 路博润公司 2018-12-25 CN disclosed
CN-1039414-C New Bis-naphthalimides for the treatment of cancer BASF AG (DE) 1998-08-05 CN disclosed
CN-1132506-A Novel bis-naphthalimides for the treatment of cancer BASF AG (DE) 1996-10-02 CN disclosed
EP-0187371-B1 SUBSTITUTED ISOQUINOLINESULFONYL COMPOUNDS Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1991-06-19 EP disclosed
US-4753966-A MIXTURE OF ZINC CARBOXYLIC ACID SALT AND AMINE CONTAINING COMPOUND BAYER AKTIENGESELLSCHAFT (DE) 1988-06-28 US disclosed
US-4678783-A CARDIOVASCULAR DISORDERS, HYPOTENSIVES, ARTERIOSCLEROSIS ASAHI KASEI KOGYO KABUSHIKI KAISHA (JP) 1987-07-07 US disclosed
EP-0187371-A2 Substituted isoquinolinesulfonyl compounds Asahi Kasei Kogyo Kabushiki Kaisha (JP) 1986-07-16 EP disclosed
US-3997461-A TRIALKYLTIN CARBOXYLATE PORTER PAINT CO. (US) 1976-12-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183168-A1 IONIZABLE LIPIDS AND COMPOSITIONS AND USES THEREOF SLC10A1, PYGL, FABP1 FDPS 1990/4885DNM1 3221/4885TSHR 2503/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.